{"name":"Azurity Pharmaceuticals","slug":"azurity-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Zonisamide Oral Product","genericName":"Zonisamide Oral Product","slug":"zonisamide-oral-product","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Zonisamide Oral Product","genericName":"Zonisamide Oral Product","slug":"zonisamide-oral-product","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPQkF4Q2oxTjdMTmI1VFBNWjVDWUsxTFRHYmRSb0dndkFNbE84VzBsc1M5aHFQMG5MQ1Z6N2VmMUVNbHNuZWFpMENRUTRwc0tQTmRsdUk0eDlNNmtic1VaTURBd2JPZ3hWZ001TEhKR2RhbklwZGwwdmYwajQ3MWNyZ0hqUnRSR3FEME9yd1JHcFFYU2FS?oc=5","date":"2026-03-25","type":"pipeline","source":"Secondaries Investor","summary":"QHP’s pharma single-asset delivers 10x for selling LPs - Secondaries Investor","headline":"QHP’s pharma single-asset delivers 10x for selling LPs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQTVhSdVhQLXFJTEVpSnducmJ4OG5OZnF3d0xITHFxZWFDVnoyYnhWT1hlRXAtdkItd2FuWTVmekEtR1NBVVgzQ1hWOG9OLTZBXzB6RTlGLUFucElGcjNkT1g5WnlCdlJPdkF2bzZaNEJoQlVYdTBtU0ZhZHNmdGNBbWVIa28wbk9tU1MyLUVqTGlnNGprUjJRTXk2dERQR3hFVE1SUFA2RXljajcweThhV3RXdVhLU2VSQU9xMURmRWhvRC1OS3hmQWhxbTR0ZEU?oc=5","date":"2026-03-18","type":"pipeline","source":"businesswire.com","summary":"QHP Announces $1.1 Billion Continuation Vehicle for Azurity Pharmaceuticals - businesswire.com","headline":"QHP Announces $1.1 Billion Continuation Vehicle for Azurity Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxPc0ROWTY0R2RqLUhIeUIwM19NQWFkaFVKMUFuR0VCU2JiSEdyaDdieDRqNERGT3lsWjg0OUY5Z3pLX1BCMHNmNFFubUpjODJxTHpkUFJjeEIyZ0hiU3lrNUloaGFMNGlzZ3ZPS1BfT2FBNWwxUWpycHRHdDNXOFRhcXRzdk5sX3NtQ3d2TmlOd2NFRy1renlMZFU3Wk1UZGNzOG5VZEstZ1YxRGh4bzJNUW1ERUNRejNWdTZmVHdRbzlzcjlodGh6SFQ2TWNfcmtUMjlvTGg5UmNfR0haNEtlN1ByOXlEZ1N0eDcxUG1lemY3bXpUalIxLTVvRXdFREhSUkFCZkI5YThXNFNvbTAxTkR3?oc=5","date":"2025-11-17","type":"pipeline","source":"GlobeNewswire","summary":"Azurity Pharmaceuticals and Sebela Pharmaceuticals Announce the Sale of Sebela’s Bowel Prep Franchise to Azurity - GlobeNewswire","headline":"Azurity Pharmaceuticals and Sebela Pharmaceuticals Announce the Sale of Sebela’s Bowel Prep Franchise to Azurity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPZ1podDhIYnpxREttQ3RYLUR1cjZNX0xUUFFzMVdDODFDeXRqMnd0N0dtZXJGTUpyY0RpeWdLSENzU2xoUkpDaE16Q0U2TFZxMlFTQ3oxTFJxc0gzeVU5VmNiRzBTUk9wYWJ1bTc3bXU0aEVlTHpMZEpuRXpjQ2VDRWo1Y3pOaER4bXBNNlNjd2lFQUFrajJ1VHRxTXhQRHkwR1hLVzNR?oc=5","date":"2025-11-12","type":"pipeline","source":"Medical Marketing and Media","summary":"Azurity Pharmaceuticals taps Ogilvy Health to elevate its global brand - Medical Marketing and Media","headline":"Azurity Pharmaceuticals taps Ogilvy Health to elevate its global brand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxOaWdwbTdoaGNTZHN4SjcxTUstbnRfM3A0bUxjTDhGX1lNTHNVcW1PeDVPcy1qaU1aUEN3N0JUTF9Hc1YtQ1J5QUxpNkhOME9mNkdzbm1sTnRiRE5CaC1vMkQwVjdBR013TWlhYktMOXlBSWJVWXJyV3pEXzlyRUgzb2FKeGVMZU1pc2lsMHFlZm40QUUwcFE2NDNxTC1ZRTlhdTV0cktvQTdnRzNwTHpjdjU3dWZyWkVuSnVPMDFHYU1RNnlxdWRsWnNpbGdpdzMyOTFOeFJZYWk3dGI2UkhhQWk3ZDQxOHl4cHBsRjB4NVlGUmdy?oc=5","date":"2025-10-23","type":"pipeline","source":"PRWeb","summary":"ACA Pharma Named Exclusive Distributor for Feraheme® in Hong Kong, Macau, Greater Bay Area, Mainland China, and Singapore - PRWeb","headline":"ACA Pharma Named Exclusive Distributor for Feraheme® in Hong Kong, Macau, Greater Bay Area, Mainland China, and Singapor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQaE5INlFmMy1USXY4VmpQOTFvdTJhT180NEZlTzhNcVJoVWo3SWN0OWllVUVfeExYbVl1cjY5b0dFMXhDT0NWRFo2c2tUSjVJSWtXUE8zZ2N6TXVUbW5hQzJLOVljaWd4ZEkxb0pDd2w5TGg5bERwT3UwdXN1b0F5bnRSM3gwQktzcjNseVBzMk5uaWZFWS1Ub1hXejVIWlBaV2gtSmxYNnQ?oc=5","date":"2025-07-21","type":"deal","source":"The Pharma Letter","summary":"Azurity inks deal to market hypertension drug Widaplik in USA - The Pharma Letter","headline":"Azurity inks deal to market hypertension drug Widaplik in USA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQaXdyaVRDa2V1LXFsRVlKWmxtZzZlTWpfMnNkcEdJcTZuQzI1aWRjM3pXZnAtdzdJRWdVVGgtR2xaclJyck9WVWlzZjh2NHZsdzdGaS1HWDJrWlRfNlpxOGdyYzlFMWl5NTZpbkY0OHNjWk41UWdvQzdyNUxJZUtJeUJlbWlXSkNIamFBaFJwT1FyNF9NYnBzWjRuRF9qNEt5bzlWWmtZYnllVDJrLWZmdTRkTkY2TmNTdWFvcjFfQUlzb1VQOUFj?oc=5","date":"2025-07-14","type":"pipeline","source":"Fierce Pharma","summary":"Formulation specialist Azurity to lay off 75 amid plans to sunset Massachusetts plant - Fierce Pharma","headline":"Formulation specialist Azurity to lay off 75 amid plans to sunset Massachusetts plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPdzlOOTZTTTRXVk42d1kzTjFoQkYzZXJOdVVGbHZUQjZYdEllanl6dElYTUV4RzdTV1pvQTJsUG9IenNOcGxQeXgyaHhtUXdRN3JOYnlhd254ZjNldGJQREtxaVB1M05tVTZuWmx1dFk2TDQ4cjVzUDRYMUV5NzlkdDB0V2NsenZRdTF1VWdvWkVpZGNIWmRuVm5UWFY?oc=5","date":"2025-06-06","type":"pipeline","source":"Secondaries Investor","summary":"QHP Capital runs single-asset CV process for pharma company – updated - Secondaries Investor","headline":"QHP Capital runs single-asset CV process for pharma company – updated","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQa1Z3U21kQ3hDemF3RUdSTmtSdGN2cGlSemM2aGxBNlA2WTl4aUVYZ01kVDM2VHVoZWotOHZXQWY4LWxSVWJiYVBKdmlRbkpZNFRjWUxMLUNQWnRLLTM1bkk4SUxqeTc0RG05ZVI2NTdXZDlYSW9sSjRQYnBST3dpUWZzMmtmekdQbktZUm9IZkhtdEU1ZEktQW0zS3RJYi1KWHFUd0ZhbFJmOWUtelN1UG5HVmdONnMt?oc=5","date":"2025-03-14","type":"pipeline","source":"prnewswire.com","summary":"Azurity Pharmaceuticals Completes Acquisition of Covis Pharma - prnewswire.com","headline":"Azurity Pharmaceuticals Completes Acquisition of Covis Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQaVM4dXR6MFlNU3M0SHY4NXBUc2NhNzJ5bFFLS2VnWnNjdHhuZ1pPZUhBQ2s2V3FQUmRKMThmSHN3TkNEb1hmNVJoMWR4cXd3OFZqaUdpUEFzY2RSVnFqaWhYVHBidFZFY0wzMUpvZTU2cXQwRFdTNk5ESTJRamJab3B5cWc1dmk5R1BjR2xyVl8wNFE?oc=5","date":"2025-03-14","type":"pipeline","source":"Pharmaceutical Executive","summary":"Azurity Pharmaceuticals Completes Covis Pharma Acquisition - Pharmaceutical Executive","headline":"Azurity Pharmaceuticals Completes Covis Pharma Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQUkExTnFYdEFTUFhCUUFWT0VfeTA5YnM1ai1OSlhnU1FmaDJVOHdxMEJsZ1dEOVByYU1lYTlfTllkbF9pYVVwMXJhZkdTcHdObkRYcU5sSXNGQkNMek92enVHbzg2SWxvcHgwb1l1NWh6MUhWR3ZlMVRGLWVoeWRRR0dVV3E0dUdETzZwUGFiT2xQdTI3?oc=5","date":"2025-03-14","type":"deal","source":"Contract Pharma","summary":"Azurity Pharmaceuticals Acquires Covis Group - Contract Pharma","headline":"Azurity Pharmaceuticals Acquires Covis Group","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQZHVINVdBUk1KSXg4ZUZidUM4MG1yT1lQaVFGVmdKUTF2X0lqYU9sSk4xU3FCdHg3Q05MVlRxWDlkTC1xbl92bGNkNVFBU2pKVTNvWm9MYk9iWEQ0ZlRMT1VQRi1GM2w1U3pEcFlla3BYcFo2RVl1MDU2UTdjNzN3ZkxNUTlXN2owekQtZzJyajFjZHk1SEVvN1dFRXlQZjJ3TjNweEtYMExXbE15SlZ3dkY3RG5Mb19JbjAyZ3VRVnM?oc=5","date":"2023-10-02","type":"pipeline","source":"White & Case LLP","summary":"White & Case advises Azurity Pharmaceuticals, Inc. on acquisition of Slayback Pharma, LLC - White & Case LLP","headline":"White & Case advises Azurity Pharmaceuticals, Inc. on acquisition of Slayback Pharma, LLC - White & Case LLP","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}